{"meta":{"query_hash":"4d53a0d75cf7","filters":{"venue":"Drug Resistance Updates"},"cohort_total":36,"direct_labels_cover":0,"predictions_cover":36,"exported":36,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4d53a0d75cf7","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drug+Resistance+Updates"},"results":[{"id":"W1964137986","doi":"10.1016/s1368-7646(02)00003-1","title":"Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway","year":2002,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":150,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Cancer Institute","keywords":"XIAP; Ovarian cancer; PI3K/AKT/mTOR pathway; Protein kinase B; Cancer research; Cisplatin; Inhibitor of apoptosis; Programmed cell death; Apoptosis; Biology; Kinase; Cancer; Signal transduction; Cancer cell; Cell biology; Caspase; Chemotherapy; Genetics","score_opus":0.009680834590482428,"score_gpt":0.23520781452432837,"score_spread":0.22552697993384593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964137986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04903374,0.94901013,0.0000047959566,0.000037248577,0.000090810056,0.0013717212,0.0002311444,0.0000037516622,0.00021664788],"genre_scores_gemma":[0.12067531,0.876807,0.0005251077,0.000009488369,0.00006435286,0.00032966016,0.00020769672,0.000053731696,0.0013276961],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748987,0.00016909503,0.0011934945,0.0005301844,0.00031857268,0.00029881013],"domain_scores_gemma":[0.99794984,0.000021685748,0.0011121625,0.0007422194,0.00013173553,0.000042351738],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034221093,0.0003800518,0.0011305728,0.00015362533,0.000035514753,0.000009657787,0.000506226,0.00034055315,0.000027144744],"category_scores_gemma":[0.000040308947,0.00029222955,0.00036964306,0.00060495053,0.00014574855,0.000007882102,0.00016861066,0.00019583969,5.409917e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029725567,0.00080771104,0.00050904707,0.031121401,0.00023173868,0.0000032230753,0.00040204657,0.000056275378,0.8372142,0.0020913014,0.00054808933,0.12671773],"study_design_scores_gemma":[0.0005715075,0.0000330929,0.00018401715,0.014989538,0.00007712253,2.800578e-7,0.000079974954,0.000006865915,0.8564706,0.00028289156,0.12698166,0.00032243284],"about_ca_topic_score_codex":0.00029330456,"about_ca_topic_score_gemma":0.0023145883,"teacher_disagreement_score":0.12643358,"about_ca_system_score_codex":0.000107670916,"about_ca_system_score_gemma":0.00029029715,"threshold_uncertainty_score":0.999953},"labels":[],"label_agreement":null},{"id":"W1965156600","doi":"10.1016/j.drup.2011.04.002","title":"The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms","year":2011,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Government of Ontario","keywords":"Efflux; Kinase; Biology; Cancer research; Pharmacology; Signal transduction; Cancer; Drug resistance; Cell biology; Genetics","score_opus":0.03263143506265965,"score_gpt":0.2976015274292069,"score_spread":0.2649700923665473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965156600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024289111,0.98924166,0.000312675,0.0008951024,0.0015750586,0.0026901392,0.00030485058,0.00037386565,0.0045823664],"genre_scores_gemma":[0.00006125392,0.88963705,0.005460809,0.00054409204,0.0005674492,0.0007701174,0.00039976626,0.0003661224,0.102193356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99399316,0.0004070251,0.0017085108,0.0016620416,0.000892024,0.0013372301],"domain_scores_gemma":[0.994274,0.00083574455,0.0012567667,0.0029311269,0.0003556075,0.00034673294],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010815411,0.0014462535,0.0032576772,0.0001941027,0.0009595597,0.00022528277,0.001347783,0.0004912399,0.00023429115],"category_scores_gemma":[0.00018002304,0.0009654578,0.0015613819,0.00093065435,0.0004176005,0.00025377184,0.00023833946,0.0011466707,0.00034326978],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023554107,0.00060360524,0.0000014426511,0.026893476,0.0027850326,0.00056286796,0.0019711212,3.0447382e-7,0.0004099339,0.21636945,0.28938273,0.45866466],"study_design_scores_gemma":[0.0011388263,0.000035462548,0.0000021365743,0.015144968,0.0012509433,0.00001937278,0.00027780543,0.0000013780503,0.0012946439,0.029135386,0.9507085,0.000990559],"about_ca_topic_score_codex":0.00013032247,"about_ca_topic_score_gemma":0.0024282204,"teacher_disagreement_score":0.6613258,"about_ca_system_score_codex":0.00061807246,"about_ca_system_score_gemma":0.0008606339,"threshold_uncertainty_score":0.9998287},"labels":[],"label_agreement":null},{"id":"W1969152525","doi":"10.1016/j.drup.2004.06.001","title":"The emergence of HIV resistance and new antiretrovirals: are we winning?","year":2004,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Human immunodeficiency virus (HIV); Resistance (ecology); Perspective (graphical); Antiretroviral therapy; Virology; Medicine; Biology; Viral load; Computer science; Artificial intelligence; Ecology","score_opus":0.032059933540730744,"score_gpt":0.3110628451451023,"score_spread":0.2790029116043716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969152525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001826979,0.99619234,0.000010112883,0.001179773,0.00023053928,0.0006235847,0.0006382771,0.000048983446,0.0010581341],"genre_scores_gemma":[0.00016030105,0.90461063,0.00014718827,0.000008880394,0.00003677561,0.0000653826,0.00034647508,0.000044138713,0.09458022],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973389,0.00038832467,0.00078365684,0.00066269265,0.00012870989,0.0006977123],"domain_scores_gemma":[0.9976843,0.0005657272,0.0007132059,0.00085889193,0.000096720505,0.00008116222],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003740809,0.00052776054,0.0014355786,0.00013476811,0.00050466816,0.00005315406,0.00075327774,0.0002888017,0.0001916941],"category_scores_gemma":[0.00019900758,0.00033047821,0.00032125763,0.00041459512,0.00077564624,0.0000942981,0.00018388766,0.00055598613,0.00044313623],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029648168,0.00015884441,0.00024022341,0.020111443,0.0016954539,0.00010107685,0.0004315887,2.8100894e-7,0.000039846716,0.0058389846,0.7107593,0.26032647],"study_design_scores_gemma":[0.0004636238,0.000020534595,0.000030128747,0.014957225,0.0002493893,0.000007655383,0.00016724509,9.798385e-9,0.00014150563,0.0005358204,0.98313797,0.00028890505],"about_ca_topic_score_codex":0.000036391917,"about_ca_topic_score_gemma":0.0006431057,"teacher_disagreement_score":0.27237865,"about_ca_system_score_codex":0.000085833904,"about_ca_system_score_gemma":0.0005682825,"threshold_uncertainty_score":0.9999147},"labels":[],"label_agreement":null},{"id":"W1971110677","doi":"10.1016/j.drup.2004.02.004","title":"New cancer therapeutics: target-specific in, cytotoxics out?","year":2004,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pyrogenesis (Canada)","funders":"","keywords":"Cancer; Clinical trial; Biomarker; Medicine; Drug development; Proteomics; Targeted therapy; Biomarker discovery; Computational biology; Drug; Cancer research; Bioinformatics; Pharmacology; Biology; Internal medicine","score_opus":0.008700666978959477,"score_gpt":0.24758091442834745,"score_spread":0.238880247449388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971110677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92529017,0.05394362,0.011750553,0.003901512,0.0007451115,0.00057104445,0.0001181884,0.00006320898,0.0036165966],"genre_scores_gemma":[0.9521315,0.018980928,0.013322489,0.0019282664,0.0006141311,0.00006217672,0.00027357804,0.0000829698,0.012603976],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988467,0.00002380987,0.00024208953,0.00041718842,0.000120355726,0.0003498694],"domain_scores_gemma":[0.99937874,0.0000060326956,0.00007497851,0.0004073379,0.000051809206,0.00008111564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090003494,0.00020513874,0.0001743245,0.000049801896,0.00006133868,0.000040310042,0.00029378696,0.00013019373,0.00005570279],"category_scores_gemma":[0.000006584309,0.00020097375,0.00008084909,0.000116376796,0.000054380343,0.0000074374466,0.00006206375,0.00012913051,0.000036919813],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021885507,0.00011762076,0.003867042,0.000034999277,0.00007813434,0.000013859487,0.0005593497,0.00054861885,0.96521163,0.0020911465,0.024962537,0.0022962054],"study_design_scores_gemma":[0.0007807819,0.000013984141,0.00073888333,0.00004579612,0.0000075823873,9.88407e-7,0.00010345474,0.0000029129324,0.46152693,0.0016430971,0.53486824,0.0002673456],"about_ca_topic_score_codex":0.00004981668,"about_ca_topic_score_gemma":0.0045967586,"teacher_disagreement_score":0.5099057,"about_ca_system_score_codex":0.00006914083,"about_ca_system_score_gemma":0.00017921267,"threshold_uncertainty_score":0.8195472},"labels":[],"label_agreement":null},{"id":"W1973344697","doi":"10.1016/j.drup.2015.01.001","title":"RhoGTPases – A novel link between cytoskeleton organization and cisplatin resistance","year":2015,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"RhoC; RHOA; RHOB; Biology; Actin cytoskeleton; Cell biology; PAK1; CDC42; Cisplatin; GTPase; Cytoskeleton; Cancer research; Kinase; Signal transduction; Cell; Genetics","score_opus":0.022949022113287282,"score_gpt":0.2889868471376309,"score_spread":0.2660378250243436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973344697","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013197624,0.99673015,0.001277356,0.00018028576,0.00007760445,0.0006510608,0.00041417056,0.000056885205,0.0004805066],"genre_scores_gemma":[0.0004161981,0.98296034,0.0032594039,0.000048579477,0.0012668365,0.00006184097,0.0056627705,0.000136554,0.0061874627],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976617,0.00015313983,0.0006722619,0.00085272035,0.00030335967,0.00035679576],"domain_scores_gemma":[0.9982269,0.00006100007,0.0005483201,0.0006452623,0.00031659775,0.00020196025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004529996,0.0005492315,0.0010233275,0.00013900126,0.00019064672,0.00012213673,0.00033542354,0.00045572026,0.0000205492],"category_scores_gemma":[0.0003757877,0.00051109423,0.00015653111,0.00047139858,0.00014238825,0.000013410477,0.0002025285,0.00023082626,0.000021962744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001737252,0.00013591553,0.00018540671,0.037285473,0.00095634453,0.000051403997,0.0002082319,0.000009026533,0.003349533,0.004061335,0.07600697,0.87757665],"study_design_scores_gemma":[0.0003339495,0.000012614783,0.000008213355,0.00307419,0.0002741623,0.0000057848197,0.000010011828,7.954164e-7,0.0014459668,0.00014045917,0.99411476,0.0005791116],"about_ca_topic_score_codex":0.000002848526,"about_ca_topic_score_gemma":0.00006412052,"teacher_disagreement_score":0.91810775,"about_ca_system_score_codex":0.000068683235,"about_ca_system_score_gemma":0.00038427574,"threshold_uncertainty_score":0.99973404},"labels":[],"label_agreement":null},{"id":"W1976097884","doi":"10.1054/drup.2001.0190","title":"Lamivudine resistance in hepatitis B: mechanisms and clinical implications","year":2001,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Lamivudine; Virology; Hepatitis B virus; Hepatitis B; Medicine; Nucleoside analogue; Seroconversion; Orthohepadnavirus; Immunology; Viral replication; Biology; Virus; Hepadnaviridae; Nucleoside; Genetics","score_opus":0.04996537674272774,"score_gpt":0.37843679687202997,"score_spread":0.32847142012930225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976097884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055193566,0.9886236,0.00010690786,0.00253693,0.00019426257,0.0015202634,0.00033154848,0.00014381745,0.006487436],"genre_scores_gemma":[0.00010708621,0.9745488,0.007567749,0.00029935234,0.00021767875,0.00047018725,0.00038501548,0.00012577476,0.016278328],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99572283,0.00031858234,0.0018239327,0.0011485219,0.00035108358,0.00063505943],"domain_scores_gemma":[0.9970987,0.00082499953,0.000577493,0.0010637594,0.00018447686,0.00025057176],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00081698206,0.00066513335,0.0032766056,0.00035947078,0.00018885011,0.0000568353,0.00031465507,0.00039492844,0.00008425487],"category_scores_gemma":[0.0007991656,0.0005834479,0.00042092378,0.0010394446,0.0003308443,0.00011829945,0.00020738423,0.00083128345,0.00013844394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017841885,0.00082264084,0.043866124,0.042896077,0.0012717692,0.0010528192,0.0002589998,3.94577e-8,0.0000012165121,0.09466539,0.1508548,0.6641317],"study_design_scores_gemma":[0.00051197177,0.000022290886,0.008119199,0.018781113,0.0007523245,0.00002160198,0.000008063831,6.964323e-7,6.342442e-7,0.004597895,0.96669847,0.00048576703],"about_ca_topic_score_codex":0.0002412334,"about_ca_topic_score_gemma":0.0653663,"teacher_disagreement_score":0.81584364,"about_ca_system_score_codex":0.00036085738,"about_ca_system_score_gemma":0.00033305012,"threshold_uncertainty_score":0.9996617},"labels":[],"label_agreement":null},{"id":"W1986171300","doi":"10.1016/j.drup.2004.06.004","title":"Prediction of drug sensitivity and drug resistance in cancer by transcriptional and proteomic profiling","year":2004,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Institute for Research in Immunology and Cancer; McGill University","funders":"National Cancer Institute; Cancer Research Society; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance; Breast Cancer Alliance; Cancer Research Institute","keywords":"Drug resistance; Proteomics; Computational biology; Drug; Biology; Bioinformatics; Drug response; Cancer; Tumor microenvironment; Drug development; Medicine; Pharmacology; Gene; Genetics","score_opus":0.01158990424308681,"score_gpt":0.2557509097724516,"score_spread":0.24416100552936476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986171300","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031110898,0.96437496,0.000034703997,0.0001724311,0.0001292588,0.0009473085,0.0031481658,0.000010182126,0.00007210956],"genre_scores_gemma":[0.0076660207,0.988841,0.00095032516,0.000030322295,0.00012801691,0.00024646436,0.0010995507,0.00005593432,0.000982387],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980278,0.00014060969,0.00060109433,0.00075831485,0.00017497064,0.000297233],"domain_scores_gemma":[0.9990988,0.00006913736,0.00034717206,0.0003073987,0.00008718324,0.000090310044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042135257,0.00040162884,0.000815687,0.00009558376,0.0000838278,0.000041749954,0.00012514598,0.00020362384,0.0000031396767],"category_scores_gemma":[0.000062677726,0.00040212282,0.00012982452,0.00015214508,0.00023169181,0.0000121041285,0.000073443065,0.0002522446,4.7986674e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004198785,0.002398092,0.011528508,0.43209746,0.003331307,0.00021568223,0.0044335113,0.000267939,0.20073232,0.012645106,0.1195211,0.20863019],"study_design_scores_gemma":[0.0009369933,0.0000151615,0.00024123212,0.010700925,0.0002961758,0.000004923445,0.00004669363,0.000004912854,0.010330248,0.00036524056,0.9764598,0.00059771095],"about_ca_topic_score_codex":0.0001512387,"about_ca_topic_score_gemma":0.0048897173,"teacher_disagreement_score":0.85693866,"about_ca_system_score_codex":0.0001361108,"about_ca_system_score_gemma":0.00046020077,"threshold_uncertainty_score":0.99984306},"labels":[],"label_agreement":null},{"id":"W1986396848","doi":"10.1016/j.drup.2008.04.001","title":"Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents","year":2008,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Fondation de France; American Association for Cancer Research","keywords":"Medicine; Biomarker; Biomarker discovery; Trastuzumab; Imatinib; Drug; Clinical trial; Breast cancer; Druggability; Personalized medicine; Sunitinib; Oncology; Cancer; Pharmacology; Bioinformatics; Cancer research; Internal medicine; Biology; Proteomics","score_opus":0.1392766723441191,"score_gpt":0.4201719401740726,"score_spread":0.2808952678299535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986396848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004401326,0.99478686,0.0000018974462,0.0019667044,0.000092531074,0.0024160896,0.000093073024,0.000015361325,0.00018735806],"genre_scores_gemma":[0.0010605725,0.997253,0.00042579585,0.000020899513,0.00010221217,0.00073844666,0.00012863084,0.00005194875,0.0002185001],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756205,0.00024000794,0.000811452,0.0005712656,0.00046029183,0.00035492942],"domain_scores_gemma":[0.9983803,0.00052920805,0.0004248497,0.00045174037,0.0001415042,0.00007239567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014179582,0.00028122324,0.0010340309,0.00024383607,0.00009964693,0.00004018622,0.00027048003,0.0001505932,0.000006599477],"category_scores_gemma":[0.00037891144,0.00019344257,0.00012625153,0.0003547504,0.000496749,0.00007105821,0.00006441647,0.0002534679,0.0000018586742],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111361,0.00011231022,0.00045522736,0.1043303,0.00021338041,0.000030860945,0.0011142761,2.8692646e-8,0.0000069974853,0.00026514646,0.0099557815,0.8834043],"study_design_scores_gemma":[0.0004174492,0.000027384782,0.0006188655,0.012918235,0.00018080887,0.00001800541,0.000434662,0.000011019926,0.00004260354,0.00006999879,0.98508763,0.00017334528],"about_ca_topic_score_codex":0.0000104759965,"about_ca_topic_score_gemma":0.000055792298,"teacher_disagreement_score":0.97513187,"about_ca_system_score_codex":0.00011301419,"about_ca_system_score_gemma":0.0002182159,"threshold_uncertainty_score":0.7888359},"labels":[],"label_agreement":null},{"id":"W1987122879","doi":"10.1016/s1368-7646(03)00024-4","title":"The interface between ErbB and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery","year":2003,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Breast Cancer Society of Canada; Cancer Research Society","keywords":"ErbB; Biology; Receptor tyrosine kinase; Receptor; Drug discovery; Signal transduction; Cancer research; Context (archaeology); Cell signaling; Bioinformatics; Cell biology; Genetics","score_opus":0.1794879031040422,"score_gpt":0.4597632419439453,"score_spread":0.2802753388399031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987122879","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039482792,0.9888625,0.00007838844,0.0064772596,0.000225968,0.0025668677,0.00047060294,0.000026427273,0.0008971205],"genre_scores_gemma":[0.00035099295,0.9856692,0.0009060206,0.00016269836,0.0002864587,0.00047394668,0.00030718272,0.00009494929,0.011748583],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99661285,0.0004264247,0.001300643,0.0007928692,0.00030496292,0.0005622268],"domain_scores_gemma":[0.99526715,0.0030693903,0.0003919193,0.0008299757,0.00014659429,0.00029493927],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023936399,0.0004449474,0.0017797295,0.00019009235,0.0002772326,0.00021433397,0.00040958772,0.00022923452,0.000020234935],"category_scores_gemma":[0.0007608687,0.00029916965,0.00024266311,0.0003029466,0.00087957503,0.00017613794,0.00018155416,0.00087827066,0.000007391382],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018295342,0.00013213375,0.0042394744,0.021370754,0.00033142348,0.000027796616,0.00024087986,6.048754e-8,6.201404e-7,0.0019428997,0.2467198,0.7248112],"study_design_scores_gemma":[0.00045658226,0.00006297731,0.00030354166,0.013355231,0.00025174447,0.000011352752,0.00043739955,8.454636e-7,0.000007858036,0.0009899351,0.9838315,0.00029101892],"about_ca_topic_score_codex":0.000010410623,"about_ca_topic_score_gemma":0.00015362096,"teacher_disagreement_score":0.7371117,"about_ca_system_score_codex":0.0002620954,"about_ca_system_score_gemma":0.0011784846,"threshold_uncertainty_score":0.99994606},"labels":[],"label_agreement":null},{"id":"W1993572662","doi":"10.1054/drup.2002.0235","title":"HIV drug resistance and implications for the introduction of antiretroviral therapy in resource-poor countries","year":2001,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Intensive care medicine; Drug resistance; Antiretroviral therapy; Developing country; Human immunodeficiency virus (HIV); Drug; Transmission (telecommunications); Resource (disambiguation); Immunology; Viral load; Pharmacology; Biology; Computer science","score_opus":0.00856328859968757,"score_gpt":0.2516728424776016,"score_spread":0.243109553877914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993572662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61812985,0.016817506,0.00017697022,0.36216086,0.0000716589,0.0014158908,0.00008168203,0.00006798698,0.0010775932],"genre_scores_gemma":[0.84781677,0.008057942,0.0029198602,0.0005455331,0.00026846296,0.00031676365,0.00025747207,0.000040198625,0.13977702],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987935,0.00004213633,0.00037798073,0.00034755885,0.00017377551,0.0002650598],"domain_scores_gemma":[0.9989943,0.00028529807,0.00014902509,0.00038768986,0.00013416052,0.000049561713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039193273,0.00018155474,0.00031512536,0.00012898823,0.00021022637,0.000032107288,0.00012355813,0.00004146872,0.00002965208],"category_scores_gemma":[0.00008382401,0.00012598261,0.00006162973,0.00035854717,0.00023544695,0.00011286561,0.000020508709,0.00009921685,0.0000047706285],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037043914,0.0002998833,0.25376874,0.00021462323,0.00021472744,0.00000796237,0.0030671947,0.0000038739113,0.0013654522,0.014678768,0.7185008,0.0041735726],"study_design_scores_gemma":[0.0020597929,0.0000166171,0.061483175,0.000096312775,0.0000556786,0.0000041227695,0.00078198564,0.000013819945,0.004956183,0.0010187316,0.9293721,0.000141511],"about_ca_topic_score_codex":0.00000702148,"about_ca_topic_score_gemma":0.00053527526,"teacher_disagreement_score":0.36161533,"about_ca_system_score_codex":0.00008828307,"about_ca_system_score_gemma":0.00007172097,"threshold_uncertainty_score":0.51374215},"labels":[],"label_agreement":null},{"id":"W2029697713","doi":"10.1016/j.drup.2008.08.005","title":"SPARC in cancer biology: Its role in cancer progression and potential for therapy","year":2008,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Matricellular protein; Cancer; Colorectal cancer; Cancer research; Biology; Tumor progression; Ovarian cancer; Cancer cell; Phenotype; Medicine; Extracellular matrix; Genetics; Gene","score_opus":0.04108337212371253,"score_gpt":0.39013273392181236,"score_spread":0.3490493617980998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029697713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021620963,0.99420404,0.0000010118414,0.0005441284,0.00015421322,0.0025700398,0.00015831151,0.000027054672,0.00017910665],"genre_scores_gemma":[0.0011718149,0.9938505,0.0001905092,0.00011883265,0.00022775054,0.0028950868,0.00012264407,0.000049917828,0.0013729396],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983233,0.000075487944,0.00051144126,0.0005569203,0.00014169165,0.00039114617],"domain_scores_gemma":[0.99938244,0.000069271104,0.0002293581,0.00019117915,0.00006420493,0.00006357204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013934504,0.00037709236,0.0015477051,0.00020854823,0.00008807272,0.000014351152,0.00010869101,0.00023442869,0.00003082936],"category_scores_gemma":[0.000029950994,0.00026073365,0.00016476476,0.00028877155,0.00014156212,0.000063264444,0.00006874092,0.00031298384,0.0000039410947],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045418425,0.00016407359,0.0015011659,0.007608241,0.00014355345,0.000054758788,0.00019550278,2.4250195e-7,0.000030990348,0.00005055812,0.0046920897,0.9851046],"study_design_scores_gemma":[0.0014125354,0.000042341715,0.00047281894,0.018123308,0.000085456704,0.000007975914,0.000043594166,0.0000036893036,0.00010400276,0.00015450931,0.97926414,0.00028559778],"about_ca_topic_score_codex":0.00019928887,"about_ca_topic_score_gemma":0.0018875399,"teacher_disagreement_score":0.98481905,"about_ca_system_score_codex":0.00016310133,"about_ca_system_score_gemma":0.00022457163,"threshold_uncertainty_score":0.9999845},"labels":[],"label_agreement":null},{"id":"W2040642086","doi":"10.1016/j.drup.2012.06.001","title":"Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii","year":2012,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":262,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Acinetobacter baumannii; Multilocus sequence typing; Biology; Microbiology; Antibiotics; Molecular epidemiology; Antibiotic resistance; Carbapenem; Outbreak; Population; Multiple drug resistance; Typing; Genetics; Virology; Gene; Medicine; Bacteria; Genotype; Pseudomonas aeruginosa; Environmental health","score_opus":0.01943733421591278,"score_gpt":0.31020780493702454,"score_spread":0.2907704707211118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040642086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030810468,0.96654254,0.00019552156,0.00006255846,0.0004117082,0.0006778553,0.0001058944,0.000011999957,0.0011814676],"genre_scores_gemma":[0.0713379,0.9249665,0.0016843701,0.000078044766,0.00029103563,0.000048241964,0.00080543413,0.000081713144,0.0007067539],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960527,0.000695317,0.0015889728,0.00081306195,0.00025185046,0.0005980912],"domain_scores_gemma":[0.996001,0.0001943839,0.0016183131,0.0017979539,0.0002539693,0.00013434967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058307423,0.0007393055,0.0023364453,0.00008436517,0.00009691252,0.000012010204,0.0013640827,0.00065364945,0.000033013188],"category_scores_gemma":[0.0002402438,0.0004989798,0.00080291094,0.00039074215,0.0008744527,0.0000128432885,0.00045268403,0.00027081862,0.000025107614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027492575,0.002613661,0.14019841,0.24731214,0.017527841,0.00015231718,0.0025995227,0.00007047201,0.04972718,0.07052216,0.062295858,0.4042312],"study_design_scores_gemma":[0.00020804626,0.000059699483,0.0012252023,0.0027667095,0.0007499917,0.000006070465,0.000072695446,5.86228e-7,0.002889323,0.00056849595,0.9908928,0.0005603585],"about_ca_topic_score_codex":0.00006971764,"about_ca_topic_score_gemma":0.00045454822,"teacher_disagreement_score":0.928597,"about_ca_system_score_codex":0.00008286064,"about_ca_system_score_gemma":0.00029071988,"threshold_uncertainty_score":0.9997462},"labels":[],"label_agreement":null},{"id":"W2068541511","doi":"10.1016/j.drup.2004.07.002","title":"Leishmaniasis: drugs in the clinic, resistance and new developments","year":2004,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":403,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"Centers for Disease Control and Prevention","keywords":"Miltefosine; Pentamidine; Leishmaniasis; Leishmania; Medicine; Antifungal drugs; Amphotericin B; Drug resistance; Antifungal; Pharmacology; Fluconazole; Intensive care medicine; Immunology; Visceral leishmaniasis; Biology; Dermatology; Internal medicine; Microbiology; Pneumonia; Parasite hosting; Computer science","score_opus":0.060267318084281464,"score_gpt":0.36601372483918543,"score_spread":0.30574640675490394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068541511","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000067791196,0.9787748,0.0000021299581,0.0041595884,0.00014288738,0.002378875,0.000041385858,0.0000912042,0.014341375],"genre_scores_gemma":[0.000057921032,0.939746,0.0023110916,0.00040273005,0.00024032708,0.00041058895,0.00014926193,0.00012883937,0.056553222],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942049,0.0005071255,0.0016177249,0.0013214949,0.0012954944,0.0010532676],"domain_scores_gemma":[0.99652505,0.0011107168,0.0005819972,0.0013008056,0.00016903637,0.00031238378],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019508366,0.0009378267,0.0030316138,0.000509827,0.0003230118,0.00023666104,0.0010159743,0.00033780828,0.000098610144],"category_scores_gemma":[0.00091934635,0.0006186926,0.00042830102,0.0013578443,0.00043180477,0.00023068905,0.00033313755,0.0014699236,0.0003512252],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005011953,0.00051788974,0.00067677884,0.10354004,0.0013383564,0.0010530477,0.007169589,6.211141e-8,3.272118e-7,0.0026628464,0.44721383,0.435326],"study_design_scores_gemma":[0.0011821365,0.000018519333,0.001099971,0.04948278,0.00046117016,0.000028086262,0.0007964158,3.0270986e-8,0.0000018796414,0.00074452953,0.9456463,0.000538216],"about_ca_topic_score_codex":0.00006782104,"about_ca_topic_score_gemma":0.0019644708,"teacher_disagreement_score":0.49843243,"about_ca_system_score_codex":0.0007002895,"about_ca_system_score_gemma":0.002057282,"threshold_uncertainty_score":0.99962646},"labels":[],"label_agreement":null},{"id":"W2071538535","doi":"10.1016/j.drup.2009.02.001","title":"Mutational ‘hot-spots’ in mammalian, bacterial and protozoal dihydrofolate reductases associated with antifolate resistance: Sequence and structural comparison","year":2009,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Antifolate; Biology; Dihydrofolate reductase; Plasmodium falciparum; Genetics; Antimetabolite; Malaria; Gene; Immunology","score_opus":0.027419261102729693,"score_gpt":0.3193452072151339,"score_spread":0.2919259461124042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071538535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10083828,0.89428943,8.689531e-7,0.00063288625,0.00009893669,0.003204757,0.0004914432,0.000105061714,0.00033835144],"genre_scores_gemma":[0.026545068,0.93899006,0.0032284565,0.000047450434,0.00017257605,0.00048607908,0.007697449,0.000145675,0.02268721],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964055,0.00026962947,0.0010936972,0.0010478053,0.0005518763,0.00063152873],"domain_scores_gemma":[0.99830824,0.0002315009,0.0007050202,0.00035196551,0.00016765673,0.0002356372],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003723382,0.00086316356,0.0024371503,0.00036377576,0.00023482097,0.00018174872,0.00016975564,0.00028733336,0.00005706422],"category_scores_gemma":[0.00014803832,0.0006396216,0.000116486124,0.0007158576,0.00032845762,0.00026660756,0.00005870358,0.00054707564,0.000008702164],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025418444,0.0031743278,0.08365779,0.12901276,0.011354293,0.022728737,0.014805173,0.0000097740785,0.0003200686,0.004531953,0.054713648,0.650273],"study_design_scores_gemma":[0.007688511,0.00015288264,0.028972244,0.08200377,0.0028327897,0.00030230306,0.00022443861,0.0000362361,0.00019556227,0.0006616826,0.87450254,0.0024270432],"about_ca_topic_score_codex":0.000011930711,"about_ca_topic_score_gemma":0.00077661005,"teacher_disagreement_score":0.8197889,"about_ca_system_score_codex":0.00042273448,"about_ca_system_score_gemma":0.0006638627,"threshold_uncertainty_score":0.99960554},"labels":[],"label_agreement":null},{"id":"W2071822666","doi":"10.1054/drup.2000.0126","title":"Biochemical mechanisms involved in overcoming HIV resistance to nucleoside inhibitors of reverse transcriptase","year":2000,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Health Canada","keywords":"Reverse transcriptase; Context (archaeology); Nucleoside; Drug resistance; Biology; Nucleoside Reverse Transcriptase Inhibitor; Enzyme; Drug; Human immunodeficiency virus (HIV); Virology; Amino acid; Genetics; Pharmacology; RNA; Biochemistry; Gene","score_opus":0.006801987319243661,"score_gpt":0.22515922886026052,"score_spread":0.21835724154101685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071822666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98108315,0.0011383888,0.00004629677,0.012072607,0.00007320155,0.0007251552,0.000080955164,0.00008917,0.0046910774],"genre_scores_gemma":[0.92276514,0.00021457454,0.026534116,0.00066949177,0.000042456337,0.00007282256,0.00014326742,0.00005131244,0.04950684],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977983,0.000058584686,0.00068622903,0.00055293954,0.00044198788,0.00046195483],"domain_scores_gemma":[0.9990538,0.00007225132,0.00009015392,0.0004655504,0.000070340386,0.00024792674],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029202312,0.00031565162,0.00059397507,0.00025513276,0.000068121546,0.000017832557,0.00017707855,0.000106973166,0.0005655698],"category_scores_gemma":[0.00007018176,0.0002972959,0.00014486891,0.00068657147,0.000087591,0.00013745409,0.000025201982,0.00019343878,0.0001384436],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007893604,0.001678354,0.025472354,0.0010519075,0.00029086418,0.00092062756,0.009563596,0.000013960515,0.31949744,0.0052626356,0.627015,0.0013396819],"study_design_scores_gemma":[0.004598878,0.000026076912,0.0039305827,0.002504603,0.00013567845,0.000003235554,0.0012042557,0.000015196205,0.7554456,0.0016952044,0.22986288,0.0005778003],"about_ca_topic_score_codex":0.000024720295,"about_ca_topic_score_gemma":0.0005581941,"teacher_disagreement_score":0.4359482,"about_ca_system_score_codex":0.00024339638,"about_ca_system_score_gemma":0.000109830886,"threshold_uncertainty_score":0.9999479},"labels":[],"label_agreement":null},{"id":"W2073200741","doi":"10.1016/j.drup.2012.03.003","title":"Immunotherapy: A useful strategy to help combat multidrug resistance","year":2012,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Cancer Institute; National Institute on Aging; Fondation des Etoiles; Owens Foundation","keywords":"Immunotherapy; Cytotoxic T cell; Multiple drug resistance; Immune system; Cancer immunotherapy; Cancer; Immunology; Medicine; Biology; Drug resistance; Internal medicine; Microbiology","score_opus":0.030832232956274443,"score_gpt":0.29738222501956013,"score_spread":0.26654999206328567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073200741","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021317422,0.9926878,0.00003751521,0.00019937119,0.0018881852,0.002135453,0.0006629806,0.0003984094,0.0017770885],"genre_scores_gemma":[0.00032468917,0.8091929,0.00025696377,0.0002565921,0.0001458744,0.000583411,0.0010454797,0.0002983036,0.1878958],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926044,0.0019273751,0.0019383577,0.0013651579,0.00020920824,0.001955511],"domain_scores_gemma":[0.9950525,0.0011356456,0.0010427971,0.0024310509,0.0002107342,0.00012725803],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0012170902,0.001714487,0.0038324255,0.00068869314,0.0007967907,0.00020428949,0.0021362063,0.001102244,0.0020550191],"category_scores_gemma":[0.00012743482,0.0014464513,0.0012105462,0.0010337511,0.00053465756,0.00042269746,0.00028332043,0.0015283256,0.0073788217],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021426207,0.0007213444,0.000013514658,0.008554398,0.0031594175,0.00004390313,0.001510259,8.3191156e-7,0.0024430305,0.0019199523,0.10900156,0.8704892],"study_design_scores_gemma":[0.0010569919,0.000050663904,0.000045571946,0.0080615785,0.0005092108,0.000039204177,0.00019522262,2.2154609e-8,0.0012985234,0.00006651186,0.98706657,0.0016099188],"about_ca_topic_score_codex":0.000059235044,"about_ca_topic_score_gemma":0.00033941274,"teacher_disagreement_score":0.878065,"about_ca_system_score_codex":0.0004146896,"about_ca_system_score_gemma":0.00052463275,"threshold_uncertainty_score":0.9995601},"labels":[],"label_agreement":null},{"id":"W2087950464","doi":"10.1016/s1368-7646(02)00021-3","title":"Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms","year":2002,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Ganciclovir; Foscarnet; Virology; Famciclovir; Herpes simplex virus; Cidofovir; Biology; Thymidine kinase; Valaciclovir; Herpesviridae; Antiviral drug; Drug resistance; Human cytomegalovirus; Nucleoside analogue; DNA polymerase; Cytomegalovirus; Virus; Polymerase; Nucleoside; Viral disease; DNA; Microbiology; Genetics","score_opus":0.03304748137064542,"score_gpt":0.3666449093710895,"score_spread":0.3335974280004441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087950464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00063017395,0.98942405,0.00008802327,0.00020510743,0.00022516206,0.0013880201,0.0002936181,0.00010043143,0.0076454184],"genre_scores_gemma":[0.0019609113,0.98705924,0.005334311,0.0002797933,0.000094100375,0.00011871319,0.000087471,0.00013356644,0.0049319],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962787,0.00032126662,0.0014481589,0.0009413242,0.00046714811,0.00054342416],"domain_scores_gemma":[0.9974432,0.00034799954,0.0006051353,0.0010349269,0.00016562795,0.00040308174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005686864,0.0007086801,0.0030339514,0.0003637879,0.00012389424,0.000057155143,0.00023314578,0.00039137554,0.00010435716],"category_scores_gemma":[0.00030168198,0.00056233566,0.0007094367,0.00074622006,0.00021464852,0.00011140303,0.00012842349,0.00049136573,0.00018064964],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021853467,0.0012103437,0.00007666645,0.026253352,0.0017743222,0.0005229791,0.00018248016,7.502094e-8,0.000006866282,0.0044758134,0.017944211,0.94733435],"study_design_scores_gemma":[0.00070010615,0.00007553306,0.000022737064,0.02219055,0.0015915474,0.000008964042,0.000027123124,3.6736859e-7,0.00019189477,0.00039021313,0.97436553,0.00043542162],"about_ca_topic_score_codex":0.000020555835,"about_ca_topic_score_gemma":0.00012752926,"teacher_disagreement_score":0.9564213,"about_ca_system_score_codex":0.00016828036,"about_ca_system_score_gemma":0.00024270226,"threshold_uncertainty_score":0.9996828},"labels":[],"label_agreement":null},{"id":"W2092643107","doi":"10.1016/j.drup.2011.01.001","title":"Creeping baselines and adaptive resistance to antibiotics","year":2011,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":228,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Antibiotic resistance; Resistance (ecology); Adaptive response; Adaptation (eye); Biology; Antibiotics; Mechanism (biology); Drug resistance; Intensive care medicine; Evolutionary biology; Biotechnology; Genetics; Medicine; Ecology; Neuroscience","score_opus":0.025393598519693174,"score_gpt":0.2899207888008317,"score_spread":0.2645271902811385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092643107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035206453,0.9942415,0.00067421613,0.00007175542,0.0003507289,0.00095624855,0.00039270733,0.000057548503,0.0029032312],"genre_scores_gemma":[0.00040737545,0.96346325,0.01633538,0.00017490512,0.00050799403,0.0000151449985,0.00045399644,0.00019560383,0.01844634],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99618214,0.00027906793,0.0009808446,0.0015625877,0.00024560269,0.00074973376],"domain_scores_gemma":[0.997399,0.000104480576,0.00058798015,0.001363241,0.00023504572,0.00031028484],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049339497,0.00093648484,0.0016382121,0.00020287072,0.00023274263,0.00013601902,0.0008528588,0.0005180823,0.000033450324],"category_scores_gemma":[0.00034890618,0.0008630737,0.00035310627,0.00040080794,0.0003321195,0.000015555921,0.00046415825,0.00032284352,0.000086411805],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024227947,0.000591365,0.0008344284,0.07140138,0.002989891,0.00033269476,0.0006876436,0.0000025761633,0.0014866625,0.017081438,0.4901262,0.41204295],"study_design_scores_gemma":[0.00015028067,0.000033495136,0.00005350245,0.009340495,0.00030156792,0.00000895339,0.000060806007,3.814088e-7,0.0006221975,0.00011063462,0.98832417,0.0009934948],"about_ca_topic_score_codex":0.000008388645,"about_ca_topic_score_gemma":0.00074128865,"teacher_disagreement_score":0.498198,"about_ca_system_score_codex":0.00006625064,"about_ca_system_score_gemma":0.00026223648,"threshold_uncertainty_score":0.999382},"labels":[],"label_agreement":null},{"id":"W2114168745","doi":"10.1016/j.drup.2015.08.001","title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","year":2015,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":330,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Sanofi Pasteur; Astellas Foundation for Research on Metabolic Disorders; Astellas Pharma; Bundesministerium für Bildung und Forschung; Cidara Therapeutics; National Institute of Allergy and Infectious Diseases; Medical Research Council; Celgene; Pfizer; Dainippon Sumitomo Pharma; Janssen Pharmaceuticals; Gilead Sciences; Radboud Universiteit; Sanofi; European Commission; Viropharma; Bristol-Myers Squibb","keywords":"Azole; Voriconazole; Micafungin; Aspergillosis; Aspergillus fumigatus; Itraconazole; Echinocandin; Medicine; Intensive care medicine; Drug resistance; Aspergillus; Amphotericin B; Esophageal candidiasis; Microbiology; Biology; Antifungal; Immunology; Fluconazole; Dermatology","score_opus":0.02548187277548414,"score_gpt":0.29582742481636504,"score_spread":0.2703455520408809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114168745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8872639,0.0048232377,0.00027233787,0.01291122,0.0012429559,0.0009131014,0.00010365147,0.0001490778,0.09232054],"genre_scores_gemma":[0.99052674,0.0024681902,0.00025093963,0.0005241955,0.00011813731,0.000046989066,0.00014674268,0.000024189236,0.0058938568],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813396,0.00007683423,0.00040692594,0.00037472483,0.00075085723,0.0002567151],"domain_scores_gemma":[0.9988011,0.00007678089,0.00016680574,0.000571263,0.00024775232,0.00013629299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005041565,0.00020838421,0.00027773346,0.00007283226,0.00009923992,0.00003187878,0.00018986453,0.00006835489,0.000160784],"category_scores_gemma":[0.000085234686,0.00014389452,0.00012696953,0.00023486912,0.0001733259,0.00011641787,0.000062791674,0.00018133757,0.000041877043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008996502,0.0015089838,0.031473152,0.00052418356,0.0011047171,0.000079424884,0.0020060723,0.000026578473,0.02239121,0.046996556,0.87996256,0.004930051],"study_design_scores_gemma":[0.0023148141,0.00015028156,0.061385144,0.00084792793,0.000045966797,0.0000015463221,0.0019379138,0.00009504702,0.034174062,0.000839199,0.8978859,0.00032215271],"about_ca_topic_score_codex":0.00007871979,"about_ca_topic_score_gemma":0.000089016554,"teacher_disagreement_score":0.10326289,"about_ca_system_score_codex":0.00026726144,"about_ca_system_score_gemma":0.000057133813,"threshold_uncertainty_score":0.5867848},"labels":[],"label_agreement":null},{"id":"W2123781894","doi":"10.1016/j.drup.2007.01.003","title":"Cell survival, cell death and cell cycle pathways are interconnected: Implications for cancer therapy","year":2007,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":452,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"Canadian Institutes of Health Research; CancerCare Manitoba Foundation; Manitoba Medical Service Foundation; Manitoba Health Research Council","keywords":"Cell cycle; Programmed cell death; Context (archaeology); Cell biology; Cyclin-dependent kinase; Biology; Cell growth; Apoptosis; Cancer research; Protein kinase B; Regulator; PI3K/AKT/mTOR pathway; Signal transduction; Genetics; Gene","score_opus":0.05591776088849937,"score_gpt":0.3349819565211766,"score_spread":0.27906419563267726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123781894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007959685,0.9876254,0.00046940555,0.00029748597,0.00046363697,0.0034079014,0.0021005431,0.00021117137,0.0046284385],"genre_scores_gemma":[0.00084769545,0.98981977,0.0014829893,0.00029508318,0.00036045327,0.0012369406,0.0011564132,0.00032709682,0.004473574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643856,0.00013096131,0.0010035655,0.0012920076,0.00030483666,0.00083004555],"domain_scores_gemma":[0.9965687,0.0005373689,0.00089477195,0.0012550094,0.00037211203,0.00037204713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041834763,0.0009168238,0.0021978656,0.00037042328,0.00026241143,0.00009749508,0.00045020925,0.0005734694,0.00009167705],"category_scores_gemma":[0.000049551312,0.0008025386,0.00069755496,0.00057686574,0.00013312942,0.000091974325,0.0001070194,0.0007529375,0.00003689004],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010037409,0.002252145,0.0004689355,0.14056705,0.0012785307,0.00019956465,0.0014304495,0.000010489193,0.004338634,0.0014788565,0.1488409,0.6981307],"study_design_scores_gemma":[0.0016633881,0.000060767168,0.000064776745,0.0066481456,0.000954256,0.000010212789,0.00012162874,0.0000040640434,0.0027270932,0.00019759446,0.9867651,0.0007829701],"about_ca_topic_score_codex":0.000081072765,"about_ca_topic_score_gemma":0.00052285707,"teacher_disagreement_score":0.8379242,"about_ca_system_score_codex":0.00052366947,"about_ca_system_score_gemma":0.00068985036,"threshold_uncertainty_score":0.9994426},"labels":[],"label_agreement":null},{"id":"W2156149052","doi":"10.1016/j.drup.2006.08.001","title":"Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: Towards personalized medicine","year":2006,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba","funders":"Canadian Space Agency; CancerCare Manitoba Foundation; Muscular Dystrophy Association; Manitoba Health Research Council; Manitoba Medical Service Foundation; Health Sciences Centre Foundation; Parent Project Muscular Dystrophy","keywords":"Personalized medicine; Cancer; Computational biology; Bioinformatics; Biology; Medicine; Genetics","score_opus":0.080257720066636,"score_gpt":0.45804743444390794,"score_spread":0.37778971437727193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156149052","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013092747,0.99280274,0.00003367704,0.0028111278,0.0000544393,0.0027431583,0.0011891341,0.000023047502,0.00021173911],"genre_scores_gemma":[0.0000329763,0.992547,0.002391721,0.00017825847,0.00020890351,0.002401824,0.000072884715,0.00008379419,0.0020826862],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978404,0.00020496105,0.0006081058,0.0006242807,0.00035916604,0.0003630522],"domain_scores_gemma":[0.99692285,0.0020462596,0.00032377112,0.00034317886,0.00015529098,0.0002086211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009849855,0.00044336836,0.001982901,0.00023827082,0.00018940019,0.000052932173,0.00016690587,0.00016787855,0.000151525],"category_scores_gemma":[0.00037602638,0.00024107457,0.00024353182,0.00038860238,0.0013207889,0.00004947611,0.0001070033,0.00021586668,3.9153133e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028594668,0.0000574118,0.0026758283,0.0378544,0.0010854629,0.0000042834786,0.00020094785,7.469978e-9,0.0000028887846,0.00027529226,0.023984844,0.9335727],"study_design_scores_gemma":[0.0011989779,0.00004774412,0.00080538716,0.011898782,0.00410633,0.000004638264,0.00015264438,0.000013438745,0.000019320425,0.000120755765,0.98139477,0.00023721454],"about_ca_topic_score_codex":0.0012803164,"about_ca_topic_score_gemma":0.00068328367,"teacher_disagreement_score":0.9574099,"about_ca_system_score_codex":0.000073814284,"about_ca_system_score_gemma":0.0002458186,"threshold_uncertainty_score":0.98307353},"labels":[],"label_agreement":null},{"id":"W2171452890","doi":"10.1054/drup.2000.0152","title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment","year":2000,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":519,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pseudomonas aeruginosa; Antibiotics; Efflux; Antibiotic resistance; Microbiology; Periplasmic space; Biology; Resistance (ecology); Bacterial outer membrane; Bacteria; Genetics; Gene; Ecology; Escherichia coli","score_opus":0.00525736061795576,"score_gpt":0.24360459976691584,"score_spread":0.23834723914896008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171452890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892837,0.002887888,0.00003146947,0.00050059427,0.00007738206,0.0003690494,0.00009000296,0.000033303157,0.0067266477],"genre_scores_gemma":[0.97608715,0.0030043488,0.0029794285,0.00017763308,0.00008868348,0.000012025628,0.00014399027,0.00005368929,0.017453076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978808,0.00011998627,0.00038397202,0.00084300176,0.00020777766,0.0005644526],"domain_scores_gemma":[0.99894005,0.000047178783,0.00010951876,0.0007214354,0.000038364113,0.00014342605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020011561,0.00046019952,0.00042135766,0.00009441363,0.00012709561,0.0000862796,0.00026191495,0.00016499395,0.00016041465],"category_scores_gemma":[0.000034464272,0.00036759028,0.00013018225,0.00020822103,0.00018249569,0.000015754906,0.000035645462,0.000111542584,0.000058718073],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02242602,0.002998432,0.1479065,0.0006198728,0.0009849104,0.0009222954,0.0016719025,0.00048125454,0.73029506,0.019738734,0.052548867,0.019406144],"study_design_scores_gemma":[0.006046035,0.000864101,0.4288797,0.0009170715,0.00010749779,0.000030785937,0.00039079422,0.000043262306,0.4490007,0.0071481564,0.10424158,0.0023303314],"about_ca_topic_score_codex":0.000044207252,"about_ca_topic_score_gemma":0.0017806435,"teacher_disagreement_score":0.2812944,"about_ca_system_score_codex":0.00014077034,"about_ca_system_score_gemma":0.000079373,"threshold_uncertainty_score":0.99987763},"labels":[],"label_agreement":null},{"id":"W2273626774","doi":"10.1016/j.drup.2016.02.001","title":"Could drugs inhibiting the mevalonate pathway also target cancer stem cells?","year":2016,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Mevalonate pathway; Cancer; Cancer stem cell; Cancer research; Carcinogenesis; Cancer cell; Metastasis; Hippo signaling pathway; Biology; Signal transduction; Epithelial–mesenchymal transition; Stem cell; Cell biology; Bioinformatics; Reductase; Genetics; Biochemistry; Enzyme","score_opus":0.013004977418209964,"score_gpt":0.2755649961688785,"score_spread":0.26256001875066853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2273626774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003619992,0.9868905,0.000032303593,0.00039133008,0.008332649,0.0007978465,0.001576302,0.000047057154,0.0018958275],"genre_scores_gemma":[0.000041033185,0.9355831,0.00009122487,0.00036891774,0.013868756,0.00049460505,0.00032836283,0.00016231489,0.049061656],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99647003,0.0003666422,0.0008498245,0.0010967393,0.00042855128,0.00078822544],"domain_scores_gemma":[0.9976615,0.00009815443,0.0007818285,0.001083078,0.00020492342,0.00017051613],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007341068,0.00079871475,0.0013513516,0.00008331416,0.00033016043,0.00012639651,0.0009538818,0.00044415848,0.00012686425],"category_scores_gemma":[0.00003317637,0.0004877157,0.0007346542,0.0002321981,0.0003369106,0.00001249104,0.0003199941,0.00042001557,0.000102336555],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054929646,0.000037189573,0.0000018462979,0.0048621157,0.00041985582,0.0000011139238,0.00016219898,0.000001792163,0.002273779,0.00053043006,0.5135236,0.47813118],"study_design_scores_gemma":[0.0002952083,0.0000069947573,3.4895962e-7,0.0044930456,0.00023388707,0.000003309826,0.000089014895,4.051619e-7,0.007858614,0.00007112975,0.9862488,0.0006992746],"about_ca_topic_score_codex":0.000037345286,"about_ca_topic_score_gemma":0.00025896452,"teacher_disagreement_score":0.47743192,"about_ca_system_score_codex":0.000110070236,"about_ca_system_score_gemma":0.0007831385,"threshold_uncertainty_score":0.99975747},"labels":[],"label_agreement":null},{"id":"W2767031674","doi":"10.1016/j.drup.2017.10.003","title":"Not only P-glycoprotein: Amplification of the ABCB1- containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins","year":2017,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministry of Health, British Columbia; Sapienza Università di Roma; Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Multiple drug resistance; Biology; Efflux; P-glycoprotein; Cancer cell; Cancer research; Drug resistance; ATP-binding cassette transporter; Epigenetics; Locus (genetics); Vinca; Gene; Cancer; Genetics; Pharmacology; Transporter","score_opus":0.034160511131234444,"score_gpt":0.31473638836263707,"score_spread":0.28057587723140265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767031674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014646816,0.9684001,0.00011843358,0.00081513077,0.0007390606,0.010288351,0.003303383,0.00017001714,0.001518705],"genre_scores_gemma":[0.14377834,0.82452273,0.001437721,0.00003916992,0.000111318186,0.0008403044,0.0016618754,0.00032072281,0.027287817],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99132186,0.0006509455,0.0035741536,0.0016255006,0.001934917,0.00089261937],"domain_scores_gemma":[0.986235,0.0002483266,0.008426139,0.0034779375,0.0012880029,0.00032454383],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0013482851,0.0013175675,0.0048921076,0.00039331906,0.00049187127,0.00006123066,0.0016997383,0.0010226169,0.00008527827],"category_scores_gemma":[0.0002344798,0.0009583204,0.0012189689,0.0008429695,0.0009610433,0.00040424918,0.0001422035,0.0012672894,0.0000045345455],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025420202,0.007027572,0.0003510589,0.4242955,0.0075554973,0.0004076548,0.006866892,0.000056361456,0.3832351,0.012598615,0.030657481,0.10152806],"study_design_scores_gemma":[0.003906821,0.00015553256,0.00033612773,0.18357591,0.0024947044,0.000007223701,0.00046896178,0.000010739785,0.23605612,0.00026835495,0.57143885,0.0012806326],"about_ca_topic_score_codex":0.00032090038,"about_ca_topic_score_gemma":0.001954725,"teacher_disagreement_score":0.5407814,"about_ca_system_score_codex":0.0006975317,"about_ca_system_score_gemma":0.0019000248,"threshold_uncertainty_score":0.99995756},"labels":[],"label_agreement":null},{"id":"W2794341756","doi":"10.1016/j.drup.2018.01.004","title":"Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018","year":2018,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Hepatitis C virus research","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"NS5A; Hepatitis C virus; NS5B; NS3; Medicine; Virology; Drug resistance; Hepacivirus; Virus; Drug development; Drug; Pharmacology; Biology; Genetics","score_opus":0.05785593860325694,"score_gpt":0.38527833261309774,"score_spread":0.3274223940098408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794341756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068063504,0.98492014,0.00004788065,0.0012468812,0.00090088916,0.0022991677,0.0027990986,0.00041363577,0.006691693],"genre_scores_gemma":[0.00017320992,0.9481309,0.0013524181,0.00040471795,0.00087330624,0.00040524954,0.0022953104,0.00028662314,0.04607827],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99055463,0.0016674072,0.0028626984,0.0022028107,0.0011626688,0.0015497714],"domain_scores_gemma":[0.9922881,0.0022423307,0.0013034418,0.0023724176,0.00088525726,0.0009084478],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00328452,0.0013456837,0.0047448436,0.0005566364,0.000810038,0.00029308576,0.0010160989,0.0009382582,0.00050710735],"category_scores_gemma":[0.004796112,0.0010824894,0.0010855563,0.0016257146,0.0022920996,0.00040943443,0.0004672068,0.002353713,0.0016289118],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026511354,0.0004989182,0.00135589,0.013476526,0.0014675118,0.00044082932,0.00021895768,3.312388e-8,0.0000024003716,0.0011954682,0.8541077,0.1269707],"study_design_scores_gemma":[0.0009117073,0.00003682937,0.00027646395,0.024101565,0.0008205778,0.000013219619,0.000017597486,0.000008116387,0.000025290492,0.0006059623,0.9722102,0.0009724233],"about_ca_topic_score_codex":0.0003287019,"about_ca_topic_score_gemma":0.035821624,"teacher_disagreement_score":0.12599826,"about_ca_system_score_codex":0.0009745129,"about_ca_system_score_gemma":0.0016816468,"threshold_uncertainty_score":0.9999479},"labels":[],"label_agreement":null},{"id":"W2800029404","doi":"10.1016/j.drup.2018.04.001","title":"Corrigendum to “Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018” [Drug Resist. Updates 37 (March) (2018) 17–39]","year":2018,"lang":"en","type":"erratum","venue":"Drug Resistance Updates","topic":"Hepatitis C virus research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Drug; Virology; Drug resistance; Medicine; Relevance (law); Hepatitis C virus; Virus; Biology; Pharmacology; Genetics; Political science","score_opus":0.03217018304041553,"score_gpt":0.32048403887188537,"score_spread":0.28831385583146985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800029404","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11833446,0.23840205,0.0006112518,0.14793622,0.12919942,0.023216743,0.08192635,0.0063024266,0.2540711],"genre_scores_gemma":[0.009090344,0.12777129,0.0032318998,0.0038295535,0.004227102,0.0006463262,0.013842166,0.00075829215,0.83660305],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9825117,0.0021121213,0.0040763565,0.0045357966,0.0031209968,0.0036430229],"domain_scores_gemma":[0.98639643,0.001596018,0.0018524632,0.0049985466,0.00257751,0.0025790217],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"category_scores_codex":[0.0053672427,0.0025042715,0.0044829394,0.0012271197,0.0020607878,0.0008163412,0.0027079994,0.0018155972,0.0021907068],"category_scores_gemma":[0.00951257,0.002329597,0.0010397359,0.0027246757,0.0031163418,0.00086433673,0.0015043805,0.0058117635,0.0030141056],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018849765,0.0006342974,0.0046539884,0.0008985268,0.0010336097,0.00060800347,0.0006958464,5.575346e-7,0.00017861919,0.0005369418,0.9880206,0.00085402606],"study_design_scores_gemma":[0.0023001428,0.00013512312,0.012174054,0.0053037615,0.0005203464,0.000013372566,0.00018610197,0.000075645454,0.00081725843,0.0019099788,0.9742983,0.002265895],"about_ca_topic_score_codex":0.0025996459,"about_ca_topic_score_gemma":0.2533631,"teacher_disagreement_score":0.5825319,"about_ca_system_score_codex":0.0021406007,"about_ca_system_score_gemma":0.003344106,"threshold_uncertainty_score":0.9995966},"labels":[],"label_agreement":null},{"id":"W2920869071","doi":"10.1016/j.drup.2018.03.003","title":"Glioblastoma cancer stem cell biology: Potential theranostic targets","year":2019,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; Children's Hospital Research Institute of Manitoba; Southlake Regional Health Center; CancerCare Manitoba","funders":"HORIZON EUROPE Marie Sklodowska-Curie Actions; Royan Institute","keywords":"Glioblastoma; Stem cell; Cancer stem cell; Biology; Cancer research; Stem cell biology; Brain cancer; Cancer; Computational biology; Medicine; Cell biology; Genetics; Gene","score_opus":0.022101269485741776,"score_gpt":0.31505085595418414,"score_spread":0.2929495864684424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920869071","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005264286,0.99265873,0.000030730178,0.00023556134,0.001731274,0.0015187097,0.0009911878,0.00011552192,0.002665644],"genre_scores_gemma":[0.00024066788,0.95192957,0.00019009518,0.00022424306,0.0006718951,0.00024429883,0.00040827334,0.00017404596,0.045916907],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969035,0.00018348782,0.00082439533,0.0010191498,0.00034438993,0.00072507194],"domain_scores_gemma":[0.9978893,0.00014083936,0.00061074935,0.0009689046,0.00015204618,0.00023817449],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023070867,0.0007945446,0.0029746208,0.00027938414,0.00011280504,0.00005627048,0.0004125235,0.0003793602,0.0011051247],"category_scores_gemma":[0.0000109521225,0.0005847544,0.0009840504,0.00046589848,0.00018551124,0.00006969893,0.00011688575,0.00062464166,0.0006871647],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030031058,0.00016086423,0.000008507243,0.06119087,0.00077301706,0.00013435014,0.00009465907,0.0000024738724,0.00010538605,0.000089312605,0.053109787,0.88403046],"study_design_scores_gemma":[0.0007280765,0.000049621267,0.0000017985054,0.010586038,0.003498488,0.00001191751,0.00003370977,0.0000017392724,0.00039690625,0.00002163187,0.9841091,0.00056098285],"about_ca_topic_score_codex":0.00006064652,"about_ca_topic_score_gemma":0.00020743476,"teacher_disagreement_score":0.9309993,"about_ca_system_score_codex":0.00033667687,"about_ca_system_score_gemma":0.00088051683,"threshold_uncertainty_score":0.999808},"labels":[],"label_agreement":null},{"id":"W3042832159","doi":"10.1016/j.drup.2020.100719","title":"FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy","year":2020,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Lopinavir; Hydroxychloroquine; Favipiravir; Ritonavir; Azithromycin; Clinical trial; Chloroquine; Pharmacology; Intensive care medicine; Virology; Immunology; Disease; Antibiotics; Coronavirus disease 2019 (COVID-19); Malaria; Virus; Internal medicine; Viral load; Biology","score_opus":0.12587865412803,"score_gpt":0.48196220077526863,"score_spread":0.3560835466472386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042832159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008622872,0.96921146,0.0017342342,0.021109086,0.00019493453,0.0066562444,0.00048587317,0.00035987972,0.00023968754],"genre_scores_gemma":[0.00008568936,0.9752555,0.001581246,0.015425025,0.0008752171,0.0021877415,0.00046098424,0.00030204165,0.0038265847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942173,0.00040445913,0.0013052777,0.0017956077,0.0011669478,0.0011104372],"domain_scores_gemma":[0.9912487,0.005906236,0.0007337342,0.0011083803,0.00037407703,0.0006288585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010331641,0.0011514755,0.004098468,0.00030965646,0.00039382014,0.00014357662,0.0009227297,0.0003142131,0.000099165765],"category_scores_gemma":[0.0038655193,0.0007679267,0.0013927392,0.0009809671,0.00065014843,0.00012753377,0.00020921421,0.0011715606,0.000108418804],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006275537,0.0005703489,0.0000064410633,0.124223225,0.0049662935,0.0003665461,0.00053741096,0.0000021816443,0.00017763423,0.00022132366,0.08466923,0.77798384],"study_design_scores_gemma":[0.004690424,0.00023730918,8.8047716e-7,0.004705299,0.0018228885,0.0000041800786,0.00005338473,0.00005372222,0.00019595577,0.00029831426,0.9871658,0.00077180634],"about_ca_topic_score_codex":0.000045267763,"about_ca_topic_score_gemma":0.00004867995,"teacher_disagreement_score":0.9024966,"about_ca_system_score_codex":0.0007154908,"about_ca_system_score_gemma":0.0037109319,"threshold_uncertainty_score":0.99947715},"labels":[],"label_agreement":null},{"id":"W4200113990","doi":"10.1016/j.drup.2021.100794","title":"An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment","year":2021,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":292,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Research Institute in Oncology and Hematology","funders":"Silesian University of Technology","keywords":"Medicine; Hydroxychloroquine; Pandemic; Lopinavir; Coronavirus disease 2019 (COVID-19); Ribavirin; Intensive care medicine; Ritonavir; Interim analysis; Clinical endpoint; Randomized controlled trial; Interim; Disease; Internal medicine; Viral load; Virology; Virus; Infectious disease (medical specialty)","score_opus":0.11328396671619102,"score_gpt":0.4875776992917716,"score_spread":0.3742937325755806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200113990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042219333,0.98559654,0.00063985336,0.008150595,0.00017674513,0.0042271614,0.00075504114,0.00022967247,0.0001821669],"genre_scores_gemma":[0.000283118,0.9839632,0.0011490507,0.00593786,0.00055908755,0.0019291154,0.0020548548,0.00022926349,0.0038944767],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99429715,0.0005523588,0.0011068264,0.0019320243,0.0010386409,0.0010729844],"domain_scores_gemma":[0.99174035,0.0047543254,0.00053186144,0.0020177928,0.00038117453,0.000574471],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008883828,0.0011434609,0.004027178,0.00037375058,0.00046194126,0.00017928869,0.0006012281,0.0003328297,0.000097500386],"category_scores_gemma":[0.0024166484,0.0007173044,0.0012794113,0.00068870845,0.00046352312,0.00011890937,0.000120194294,0.0006345221,0.0001066383],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003423296,0.0024782328,0.000012812625,0.063143104,0.0055179116,0.0011524905,0.0003991605,0.000016886102,0.00002055902,0.0023427967,0.023163281,0.89832944],"study_design_scores_gemma":[0.002598856,0.00084410637,0.0000026137393,0.008337136,0.0033118865,0.0000055440596,0.00008659492,0.00002113741,0.00010347715,0.00030956438,0.9836964,0.0006826796],"about_ca_topic_score_codex":0.00006787918,"about_ca_topic_score_gemma":0.00029335383,"teacher_disagreement_score":0.96053314,"about_ca_system_score_codex":0.0016978938,"about_ca_system_score_gemma":0.0039161495,"threshold_uncertainty_score":0.9995278},"labels":[],"label_agreement":null},{"id":"W4211153257","doi":"10.1016/j.drup.2003.10.002","title":"DNA methylation and cancer therapy","year":2003,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"DNA methylation; CpG site; Methylation; Biology; DNA methyltransferase; Epigenomics; RNA-Directed DNA Methylation; Methyltransferase; DNA; Illumina Methylation Assay; Epigenetics of physical exercise; Epigenetics; Cancer epigenetics; Cancer research; Genetics; Molecular biology; Gene; Gene expression","score_opus":0.026668337005175558,"score_gpt":0.3297473750495071,"score_spread":0.3030790380443315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211153257","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005031818,0.99776983,0.00007256731,0.000035421428,0.00017864397,0.00037766717,0.00006897416,0.000010621589,0.0009831074],"genre_scores_gemma":[0.0000610999,0.9926135,0.00042527908,0.00004664714,0.00019109264,0.00012520164,0.00052960677,0.000059799546,0.005947753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985947,0.00019248817,0.00034443138,0.00052509736,0.00012818251,0.00021512402],"domain_scores_gemma":[0.9991833,0.000032508637,0.00026447902,0.0003776584,0.00007293281,0.00006914716],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026870472,0.00032830142,0.0005455446,0.00006663772,0.00009616883,0.000054777687,0.000147377,0.00026640794,0.0000327934],"category_scores_gemma":[0.00003207344,0.00027497404,0.00016061563,0.00013569887,0.000064785534,0.0000036637134,0.000039477018,0.00011757195,0.000006266093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001295322,0.000020225923,0.000021104592,0.001269133,0.00013832665,9.69174e-7,0.000020059355,0.0000010181828,0.0011588042,0.00013372222,0.0024477842,0.9947759],"study_design_scores_gemma":[0.00013989856,0.000011587171,0.0000089684345,0.00050998665,0.00008775597,4.6943484e-7,0.000004300351,3.33866e-7,0.005102828,0.0002064266,0.9936104,0.000317063],"about_ca_topic_score_codex":0.0000058530645,"about_ca_topic_score_gemma":0.000069771864,"teacher_disagreement_score":0.99445885,"about_ca_system_score_codex":0.000023053612,"about_ca_system_score_gemma":0.00012581452,"threshold_uncertainty_score":0.99997026},"labels":[],"label_agreement":null},{"id":"W4387731505","doi":"10.1016/j.drup.2023.101012","title":"Antibiotic failure: Beyond antimicrobial resistance","year":2023,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":228,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Perelman School of Medicine, University of Pennsylvania; Defense Threat Reduction Agency; Killam Trusts; Brain and Behavior Research Foundation; National Institute of General Medical Sciences; United Therapeutics Corporation; International Association for Dental Research; University of British Columbia; University of Pennsylvania; National Institutes of Health; ACE Foundation; Procter and Gamble","keywords":"Antibiotic resistance; Antibiotics; Intensive care medicine; Medicine; Sepsis; Antimicrobial; Microbiome; Biology; Microbiology; Immunology; Bioinformatics","score_opus":0.014720306058480846,"score_gpt":0.2833561460175726,"score_spread":0.26863583995909174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387731505","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035160093,0.99332124,0.00004416396,0.00023973284,0.0010428734,0.0011931574,0.0009671331,0.00021824855,0.0026218619],"genre_scores_gemma":[0.00011915117,0.9167069,0.0024009356,0.00012464098,0.0009940229,0.000037926926,0.0036640698,0.00043789382,0.07551446],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99426013,0.00039537242,0.0015093386,0.0020967193,0.0004989973,0.00123942],"domain_scores_gemma":[0.9960614,0.00014137929,0.0010630488,0.00227685,0.00020810048,0.00024924474],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00063490344,0.0013225654,0.0024062302,0.00030744876,0.00035905192,0.00031554326,0.0017688482,0.0009507719,0.000051649295],"category_scores_gemma":[0.00034460702,0.0012420345,0.0010094545,0.00096357876,0.000559817,0.0000209646,0.00054614164,0.0006088631,0.0009118116],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017302627,0.00015033166,0.00006901849,0.046185996,0.0010306726,0.0002226513,0.000041436055,9.024533e-7,0.001082355,0.001084996,0.9375142,0.012444452],"study_design_scores_gemma":[0.0002886075,0.000013893706,0.000020562402,0.012793314,0.0004630923,0.000016494067,0.000031379594,1.3813369e-7,0.00091436825,0.00011187333,0.9840173,0.0013289915],"about_ca_topic_score_codex":0.0000056913273,"about_ca_topic_score_gemma":0.0012906833,"teacher_disagreement_score":0.07661433,"about_ca_system_score_codex":0.00014478891,"about_ca_system_score_gemma":0.0006163245,"threshold_uncertainty_score":0.99995255},"labels":[],"label_agreement":null},{"id":"W4407599227","doi":"10.1016/j.drup.2025.101213","title":"Sanfetrinem, an oral β-lactam antibiotic repurposed for the treatment of tuberculosis","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"H2020 Marie Skłodowska-Curie Actions; FP7 People: Marie-Curie Actions; National Institutes of Health; Universidad de Zaragoza; National Institute of Allergy and Infectious Diseases; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; European Commission; Horizon 2020 Framework Programme","keywords":"Antibiotics; Medicine; Lactam; Tuberculosis; Microbiology; Chemistry; Biology; Pathology","score_opus":0.0657759882485501,"score_gpt":0.4339001372049818,"score_spread":0.36812414895643164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407599227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.952772,0.03250471,0.00030810243,0.005750358,0.0021404272,0.0018119608,0.00050061045,0.000105046885,0.004106759],"genre_scores_gemma":[0.9795031,0.009910298,0.0010390545,0.0014103891,0.0001784271,0.0001229189,0.00008643094,0.000028032686,0.0077213454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982834,0.00027300988,0.00047110938,0.00040648066,0.00012934025,0.00043668284],"domain_scores_gemma":[0.9981829,0.0008649175,0.00016552418,0.00048248068,0.00018022922,0.00012393213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005605721,0.00027849042,0.00043573987,0.00014565051,0.0003613621,0.00003125038,0.00043207876,0.00013970582,0.00024269389],"category_scores_gemma":[0.000062370775,0.00019830976,0.00021888486,0.00042045434,0.00025844018,0.0000799617,0.000035729554,0.0001618428,0.000012352425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008455484,0.009004921,0.029319992,0.00079914526,0.0043956814,0.000035498037,0.004399977,0.0018352867,0.30087984,0.03455114,0.13311887,0.47320417],"study_design_scores_gemma":[0.0022362538,0.00006076068,0.003247507,0.000013575562,0.00058096077,4.8651975e-7,0.00014596741,0.0015446455,0.33746833,0.00087185274,0.6536742,0.00015547095],"about_ca_topic_score_codex":0.0000346595,"about_ca_topic_score_gemma":0.00021231172,"teacher_disagreement_score":0.5205553,"about_ca_system_score_codex":0.00006614984,"about_ca_system_score_gemma":0.000107012274,"threshold_uncertainty_score":0.8086837},"labels":[],"label_agreement":null},{"id":"W4410266122","doi":"10.1016/j.drup.2025.101251","title":"MicroRNA-mediated PTEN downregulation as a novel non-genetic mechanism of acquired resistance to PI3Kα inhibitors of head & neck squamous cell carcinoma","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre; University Health Network","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero della Salute; Fondazione AIRC per la ricerca sul cancro ETS","keywords":"PTEN; Downregulation and upregulation; Head and neck squamous-cell carcinoma; Cancer research; microRNA; PI3K/AKT/mTOR pathway; Head and neck; Mechanism (biology); Medicine; Head and neck cancer; Basal cell; Oncology; Internal medicine; Biology; Cancer; Signal transduction; Gene; Genetics; Surgery","score_opus":0.005825822523603009,"score_gpt":0.23790518535370522,"score_spread":0.23207936283010222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410266122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98987657,0.0035606187,0.0035125127,0.00042953904,0.00030633158,0.0005732315,0.0002668011,0.00002502695,0.0014493903],"genre_scores_gemma":[0.9846965,0.00004912595,0.007970169,0.0002908298,0.000103446226,0.00007162536,0.00029000104,0.00005193554,0.0064763343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762017,0.000070272974,0.0007732556,0.000742341,0.00034274173,0.00045119552],"domain_scores_gemma":[0.9980111,0.00007128835,0.00041840415,0.0009302453,0.00044011493,0.00012882992],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023103872,0.00035531298,0.00046485217,0.00021112697,0.00009431734,0.000025549138,0.00054696976,0.0002466265,0.000028048713],"category_scores_gemma":[0.00020095336,0.0003843919,0.00017411978,0.0005982344,0.00016060419,0.000010953445,0.0001844316,0.00007620296,0.000014643715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008600213,0.0001522664,0.0015386515,0.00037800928,0.000038997227,0.0000023601438,0.0002311968,0.00017570527,0.9839229,0.00018383919,0.012464154,0.000051903502],"study_design_scores_gemma":[0.0013948104,0.000077059754,0.0052467524,0.00022668755,0.00005758933,8.1530254e-7,0.000111294205,0.000025459503,0.97339725,0.00038759943,0.018722113,0.00035254855],"about_ca_topic_score_codex":0.00015442209,"about_ca_topic_score_gemma":0.0016049241,"teacher_disagreement_score":0.010525626,"about_ca_system_score_codex":0.0000960211,"about_ca_system_score_gemma":0.00033108256,"threshold_uncertainty_score":0.9998608},"labels":[],"label_agreement":null},{"id":"W4413147816","doi":"10.1016/j.drup.2025.101291","title":"Defining homologous recombination deficiency status in pancreatic ductal adenocarcinoma: Clinical implications for evaluating response to platinum chemotherapy","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"Science and Technology Planning Project of Guangdong Province; Guangzhou Science and Technology Program key projects; National Natural Science Foundation of China","keywords":"Pancreatic ductal adenocarcinoma; Homologous recombination; Chemotherapy; Medicine; Oncology; Adenocarcinoma; Internal medicine; Pancreatic cancer; Biology; Genetics; Cancer; Gene","score_opus":0.03174208239471961,"score_gpt":0.40307234455219065,"score_spread":0.37133026215747106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413147816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635332,0.0037900314,0.0024699531,0.026892275,0.00025391037,0.0016244913,0.0000885309,0.00011706284,0.0012304956],"genre_scores_gemma":[0.96609795,0.00020490383,0.027577998,0.0021319666,0.000044714478,0.0009302756,0.00013165682,0.00003845622,0.002842067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973764,0.00030894123,0.00093534245,0.0006584081,0.00020781528,0.0005131304],"domain_scores_gemma":[0.99670386,0.002077501,0.0002226163,0.0005531258,0.00031582537,0.0001270703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002300104,0.00021937123,0.0004940726,0.00041000784,0.0002149451,0.00004321228,0.00017608672,0.000120970995,0.000046645724],"category_scores_gemma":[0.0023821187,0.00022910522,0.0001300022,0.00095295557,0.00011192946,0.00010754962,0.00003338604,0.00024399832,0.000018835013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018785525,0.00074164773,0.9011175,0.00029670534,0.00011244642,0.000011190621,0.0020442922,0.00009182449,0.022394016,0.021125287,0.02006494,0.013214626],"study_design_scores_gemma":[0.007209543,0.0003060477,0.9669879,0.0005674593,0.00007566225,0.0000081728185,0.00046127065,0.00024259255,0.0030173908,0.017496027,0.003362408,0.0002654914],"about_ca_topic_score_codex":0.000020635161,"about_ca_topic_score_gemma":0.0000950328,"teacher_disagreement_score":0.065870434,"about_ca_system_score_codex":0.0006036848,"about_ca_system_score_gemma":0.0006642674,"threshold_uncertainty_score":0.93426394},"labels":[],"label_agreement":null},{"id":"W4415641574","doi":"10.1016/j.drup.2025.101319","title":"ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China; Foundation for Innovative Research Groups of the National Natural Science Foundation of China; Foundation for Innovative Research Groups of Hubei Province of China; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Breast Cancer Research Foundation","keywords":"Synthetic lethality; Poly ADP ribose polymerase; PARP inhibitor; Ovarian cancer; DNA damage; DNA repair; Olaparib; Programmed cell death","score_opus":0.011116964085680128,"score_gpt":0.30246942756489226,"score_spread":0.2913524634792121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415641574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9545513,0.0024445495,0.00023490257,0.036231752,0.0004000402,0.0008419981,0.00017327604,0.00011473072,0.0050074914],"genre_scores_gemma":[0.99327356,0.0011951906,0.00027936068,0.002724718,0.00010160961,0.00030367705,0.0001202893,0.000025999698,0.0019756039],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810135,0.00016769636,0.00047189655,0.00058959477,0.00029377794,0.00037568194],"domain_scores_gemma":[0.9989924,0.0002204952,0.00010822407,0.0003666686,0.0001625034,0.00014973528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000546208,0.000236809,0.00042035023,0.00040461437,0.00013378091,0.000055698925,0.00006405922,0.0001292126,0.00028992372],"category_scores_gemma":[0.00021762509,0.00023741687,0.000052536994,0.0008207068,0.00020785166,0.00016290597,0.000040285453,0.00028011913,0.00001891426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012793118,0.00066578895,0.09133832,0.0022086112,0.0003755084,0.00028128072,0.004618005,0.00008528855,0.7916487,0.0117717,0.08019455,0.004019149],"study_design_scores_gemma":[0.007427068,0.000091937414,0.13916968,0.0041856263,0.00011553614,0.00001524176,0.0013311887,0.00010087749,0.73985577,0.004780767,0.10230867,0.0006176727],"about_ca_topic_score_codex":0.00064122176,"about_ca_topic_score_gemma":0.0045476407,"teacher_disagreement_score":0.05179294,"about_ca_system_score_codex":0.00050467986,"about_ca_system_score_gemma":0.00024096908,"threshold_uncertainty_score":0.96815795},"labels":[],"label_agreement":null},{"id":"W7117586634","doi":"10.1016/j.drup.2025.101349","title":"AMPKα2 attenuates doxorubicin induced ferroptosis by promoting NCOA4 degradation in triple negative breast cancer","year":2025,"lang":"en","type":"article","venue":"Drug Resistance Updates","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Medical and Health Research Project of Zhejiang Province; Natural Science Foundation of Ningbo; Higher Education Discipline Innovation Project; Natural Science Foundation of Zhejiang Province; National Natural Science Foundation of China","keywords":"Triple-negative breast cancer; Doxorubicin; Degradation (telecommunications); Breast cancer; Cancer; Apoptosis","score_opus":0.010150329936666574,"score_gpt":0.2806916703124635,"score_spread":0.2705413403757969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117586634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672327,0.0025352524,0.000027800686,0.02700824,0.00023188624,0.0010065106,0.00015233392,0.0001238384,0.0016814319],"genre_scores_gemma":[0.99113995,0.00072716805,0.00034079351,0.00122566,0.00007501157,0.00057161227,0.0001385915,0.000042115855,0.0057390947],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975705,0.00016844881,0.00065653934,0.0006968921,0.00036836218,0.00053921674],"domain_scores_gemma":[0.99884844,0.00014699882,0.00023676064,0.0003820984,0.00025688694,0.00012883497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048127127,0.00034756295,0.00061987963,0.00029896465,0.00018267854,0.00008755196,0.00022029967,0.00014186914,0.00020117608],"category_scores_gemma":[0.00017756746,0.0003083191,0.0001231452,0.0014212867,0.00009756235,0.00028837443,0.0000706594,0.0004051417,0.000014775418],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022898857,0.0011912136,0.5623966,0.0013023071,0.00047096697,0.000022584898,0.003397057,0.000010878579,0.21188036,0.0007279586,0.15602927,0.060280927],"study_design_scores_gemma":[0.005877025,0.000067393565,0.24871106,0.0042154416,0.0003069725,0.0000038793783,0.0032983695,0.00071547396,0.7267988,0.00057091925,0.008676149,0.00075854536],"about_ca_topic_score_codex":0.0017547837,"about_ca_topic_score_gemma":0.0049611987,"teacher_disagreement_score":0.5149184,"about_ca_system_score_codex":0.0005316912,"about_ca_system_score_gemma":0.00026375477,"threshold_uncertainty_score":0.9999369},"labels":[],"label_agreement":null}]}